3D Systems Corporation (DDD)
🔔 Watch stock
symbol.quality_heading
We found at least one documented issue that threatens the company itself — regardless of how the stock is currently valued.
The auditor withheld its opinion on internal control over financial reporting as of December 31, 2025 — two material weaknesses persist, one of them in the revenue process — while a formal SEC investigation has been running since April 2022 and a securities class action since June 2025. At the same time operating cash flow stayed negative for the third year running (2025: minus $87.8 million), while the only reported annual profit of $29.9 million came entirely from a $139.6 million book gain on divested subsidiaries. The decision is yours.
symbol.quality_note
3D Systems invented industrial 3D printing and has been listed since 1990. For 2025 the company reported its first annual profit in years: $29.9 million. The same income statement shows a $96.1 million operating loss and a $139.6 million gain from selling the software units. Operations consumed $87.8 million in cash. On May 14, 2026 shareholders doubled authorized capital to 440 million shares; three weeks later the company sold 16.4 million new shares at $3.05 — 15.5 percent below the market price printed on the same prospectus cover. For 2025 the auditor declined to certify internal control over financial reporting. Not investment advice — just the arithmetic of who ends up paying for the new shares.
Read the analysis
Stock Watch
This analysis is as of July 27, 2026. Stock Watch will tell you what's changed at DDD since then.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 9 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 2.60 $ — 44% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
Uses AI3D Systems setzt künstliche Intelligenz und maschinelles Lernen laut Geschäftsbericht (10-K) 2025 in der eigenen proprietären Drucker-Software 3D Sprint ein, die 3D-Inhaltsdaten aufbereitet und den additiven Fertigungsprozess steuert; im 10-K 2024 wird derselbe Einsatz für die Softwareplattformen 3D Sprint, 3DXpert und Oqton beschrieben. Eine KI-Umsatzquelle weisen die Berichte nicht aus — im Gegenteil: die beiden KI-nächsten Plattformen 3DXpert und Oqton wurden am 31. Oktober 2025 an Hubb Global Holdings verkauft. Damit liegt operativer KI-Einsatz vor, aber kein KI-Geschäftsmodell.
View the full file — quotes, sources, reviewed filings
„3D Sprint uses artificial intelligence and machine learning, user-friendly interfaces, and automated setup processes. This proprietary software prepares and optimizes 3D content data and manages the additive manufacturing process for our polymer 3D printing technologies."
„3D Sprint nutzt künstliche Intelligenz und maschinelles Lernen, benutzerfreundliche Oberflächen und automatisierte Einrichtungsprozesse. Diese proprietäre Software bereitet 3D-Inhaltsdaten auf, optimiert sie und steuert den additiven Fertigungsprozess für unsere Polymer-3D-Drucktechnologien.“
„Through these platforms, the Company will continue to offer software solutions for design, build preparation simulation, automation of repetitive tasks, inspection, preparing and optimizing CAD and polygon data, increasingly leveraging the power of artificial intelligence and machine learning to drive efficiency, improved workflows, higher productivity, repeatability, and quality."
„Über diese Plattformen wird das Unternehmen weiterhin Softwarelösungen für Konstruktion, Bauvorbereitungs-Simulation, Automatisierung wiederkehrender Aufgaben, Prüfung sowie Aufbereitung und Optimierung von CAD- und Polygondaten anbieten und dabei zunehmend die Kraft von künstlicher Intelligenz und maschinellem Lernen nutzen, um Effizienz, verbesserte Arbeitsabläufe, höhere Produktivität, Wiederholgenauigkeit und Qualität zu erreichen.“
Filings Reviewed: 10-Q 2026-05-11 · 10-Q 2025-11-04 · 10-Q 2025-08-11 · 10-Q 2025-05-12 · 10-K 2026-03-09 · 10-K 2025-03-27
Rated on July 27, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 53.8% above the current price.
- Consensus
- Hold
- Analyst Ratings
- 4
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.15 | -0.24 – -0.06 | 389 | 60.8% | 4 |
| 12/31/2027 | -0.13 | -0.22 – -0.04 | 406 | 12.1% | 4 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- -0.12 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.25 | – | 111 | -3.30 | -30.40 | -8 | -13 |
| 2025: Q1 | -0.28 | – | 95 | -8.10 | -39.10 | -34 | -37 |
| 2025: Q2 | 0.81 | – | 95 | -16.30 | 110.10 | -26 | -29 |
| 2025: Q3 | -0.14 | – | 91 | -19.20 | -19.80 | -14 | -16 |
| 2025: Q4 | -0.15 | – | 106 | -4.30 | -18.40 | -15 | -17 |
| 2026: Q1 | -0.03 | – | 96 | 1.10 | -4.60 | -7 | -9 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 633 | -38 | -38 | -0.35 | 57 | 630 | 849 |
| 2017 | 646 | -54 | -66 | -0.59 | 26 | 619 | 897 |
| 2018 | 688 | -43 | -46 | -0.41 | 5 | 578 | 826 |
| 2019 | 636 | -57 | -70 | -0.61 | 32 | 522 | 807 |
| 2020 | 557 | -119 | -150 | -1.27 | -20 | 431 | 733 |
| 2021 | 616 | -33 | 322 | 2.55 | 48 | 842 | 1,549 |
| 2022 | 538 | -117 | -123 | -0.96 | -70 | 750 | 1,447 |
| 2023 | 488 | -102 | -370 | -2.85 | -81 | 421 | 980 |
| 2024 | 440 | -277 | -256 | -1.94 | -45 | 176 | 609 |
| 2025 | 387 | -95 | 30 | 0.24 | -88 | 240 | 522 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Assessment: Opportunities & Risks
The only annual profit in years — $29.9 million for 2025 — rests on a "gain on disposition" line of $139.6 million from selling the software units. The operating result was negative $96.1 million and operations consumed $87.8 million of cash, more than in 2024 ($44.9 million) or 2023 ($80.7 million).
The operating loss shrank from $406.0 million (2023) through $277.4 million (2024) to $96.1 million (2025), and to $6.6 million in the first quarter of 2026; the net loss in that quarter fell from $37.0 million to $4.4 million. Gross margin rose to 35.9 percent and Healthcare Solutions grew 21.3 percent to $50.1 million (each Q1 2026 versus the prior-year quarter).
The improvement was paid for out of substance: research halved to $9.6 million in the first quarter of 2026 (down 51.0 percent), selling and administrative expense cut 37.0 percent, headcount down 22.6 percent to 1,418 within a year, and the software division sold. On top of that, $2.6 million of the quarterly result came from a dilution book gain at the NAMI joint venture and $2.6 million from currency effects.
On May 14, 2026 shareholders doubled authorized capital to 440 million shares; on June 3, 2026 the company placed 16,393,443 new shares at $3.05 — 15.5 percent below the $3.61 price stated on the same prospectus. Shares outstanding rose to 162,450,658, and the 2030 convertible note at $2.24 could arithmetically create another 41.0 million.
Deloitte & Touche declined to certify internal control over financial reporting as of December 31, 2025; two material weaknesses persist, one of them in the revenue process. A formal SEC investigation has run since April 15, 2022, a securities class action since June 13, 2025, alongside eight stayed shareholder derivative suits.
As of March 31, 2026, $85.1 million of cash and $234.3 million of equity faced only $96.0 million of financial debt, with roughly $46.2 million of net proceeds arriving in June 2026. The 2030 note covenant — at least $20.0 million of qualified cash — was halved from $40.0 million in December 2025 in exchange for $1.8 million paid to the noteholders.
At 3D Systems a low price-to-earnings ratio and a loss-making business sit in the same data set — because the reported 2025 net income of $29.9 million comes from a $139.6 million book gain on sold software units, while the business lost $96.1 million at the operating line and burned $87.8 million of cash. The turnaround progress is real (an operating loss of just $6.6 million in the first quarter of 2026) but it was paid for with halved research, 22.6 percent fewer employees and 16.4 million new shares at a 15.5 percent discount. On top of that sits an auditor who considers internal control over financial reporting ineffective as of December 31, 2025. Not investment advice.
- 3D Systems did not reach our research list through a scanner hit — a live query on July 27, 2026 returned an empty scanner list for the ticker DDD, and those lists are recalculated daily. The hooks were the chain of capital measures in the EDGAR stream (confidential shelf registration on April 17, doubling of authorized capital on May 14, offering on June 3, 2026) and the contradiction between a 5.8 price-to-earnings ratio and an operating margin of minus 6.7 percent (data as of July 27, 2026).
- Valuation is deliberately anchored on the filings rather than on the data feed: 162,450,658 shares after the offering, valued at the $3.05 offering price and at the $3.61 documented market price (both June 3, 2026), give roughly $495 million to $586 million of market value. The market capitalization from fundamental data deviates from that by more than a fifth and is therefore not used as an anchor here; the share count itself matches the filings.
- Easy to confuse: the "gain on disposition" line of $139.6 million appears only in 2025 and stems from the sale of Geomagic (to Hexagon AB) plus 3DXpert and Oqton (to Hubb Global Holdings) — it is not recurring income. Trailing earnings per share of $0.44, on which the low P/E rests, therefore cannot be extrapolated; analyst estimates for the current and the coming year are negative.
About the Company
3D Systems Corporation provides 3D printing and digital manufacturing solutions in North and South America, Europe, the Middle East, Africa, the Asia Pacific, and Oceania. The company operates through two segments, Healthcare Solutions and Industrial Solutions.
| Employees | 1,418 |
|---|---|
| Headquarters | Rock Hill, SC |
| Address | 333 Three D Systems Circle, 29730 Rock Hill, United States |
| Phone | 803 326 3900 |
| Website | 3dsystems.com |
| IPO Date | 5. Nov 1990 |
| ISIN | US88554D2053 |
| Stock Split | 3:2 on 02/25/2013 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Jeffrey Alan Graves Ph.D. | President, CEO & Director | 1961 |
| Charles W. Hull | Co-Founder, Executive VP, CTO of Regenerative Medicine & Director Emeritus | 1940 |
| Phyllis B. Nordstrom | Executive VP, CFO & Chief Administrative Officer | 1979 |
| Joseph Zuiker | Executive Vice President of Engineering & Operations | 1965 |
| Reji Puthenveetil | Executive VP of Additive Solutions & Chief Commercial Officer | 1969 |
| Andrew William-Banasick Wright J.D. | Senior VP of General Counsel & Corporate Secretary | 1970 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.